VENETOCLAX DOSING REGIMENS FOR USE IN TREATING MYELODYSPLASTIC SYNDROMES IN COMBINATION WITH AZACITIDINE
The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine for treating myelodysplastic syndromes (MDS). La invención que se describe en el presente documento se refiere a regímenes de dosificación terapéutica que compren...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | AINSWORTH William, B KYE Steve, H HAYSLIP John |
| description | The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine for treating myelodysplastic syndromes (MDS).
La invención que se describe en el presente documento se refiere a regímenes de dosificación terapéutica que comprenden la administración de venetoclax en combinación con azacitidina para el tratamiento de los síndromes mielodisplásicos (MDS). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2023013364A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2023013364A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2023013364A3</originalsourceid><addsrcrecordid>eNqNyrEKwjAQgOEuDqK-w-Eu1EbcY3JtD5qLJKm2LqVIxEG0UN8fLfgATv_wf_PkfkLGYFUlG9DWExfgsCCD7CG3DmqPQAzBoQzTNC1WVrf-WEkfSIFvWTtr0E9KWXMg_kLLcKZQgrxIRYE0MS6T2a1_jHH16yJZ5xhUuYnDq4vj0F_jM74702RpJtKtEPudFH-hD9jkNp4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VENETOCLAX DOSING REGIMENS FOR USE IN TREATING MYELODYSPLASTIC SYNDROMES IN COMBINATION WITH AZACITIDINE</title><source>esp@cenet</source><creator>AINSWORTH William, B ; KYE Steve, H ; HAYSLIP John</creator><creatorcontrib>AINSWORTH William, B ; KYE Steve, H ; HAYSLIP John</creatorcontrib><description>The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine for treating myelodysplastic syndromes (MDS).
La invención que se describe en el presente documento se refiere a regímenes de dosificación terapéutica que comprenden la administración de venetoclax en combinación con azacitidina para el tratamiento de los síndromes mielodisplásicos (MDS).</description><language>eng ; spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231127&DB=EPODOC&CC=MX&NR=2023013364A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231127&DB=EPODOC&CC=MX&NR=2023013364A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>AINSWORTH William, B</creatorcontrib><creatorcontrib>KYE Steve, H</creatorcontrib><creatorcontrib>HAYSLIP John</creatorcontrib><title>VENETOCLAX DOSING REGIMENS FOR USE IN TREATING MYELODYSPLASTIC SYNDROMES IN COMBINATION WITH AZACITIDINE</title><description>The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine for treating myelodysplastic syndromes (MDS).
La invención que se describe en el presente documento se refiere a regímenes de dosificación terapéutica que comprenden la administración de venetoclax en combinación con azacitidina para el tratamiento de los síndromes mielodisplásicos (MDS).</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQgOEuDqK-w-Eu1EbcY3JtD5qLJKm2LqVIxEG0UN8fLfgATv_wf_PkfkLGYFUlG9DWExfgsCCD7CG3DmqPQAzBoQzTNC1WVrf-WEkfSIFvWTtr0E9KWXMg_kLLcKZQgrxIRYE0MS6T2a1_jHH16yJZ5xhUuYnDq4vj0F_jM74702RpJtKtEPudFH-hD9jkNp4</recordid><startdate>20231127</startdate><enddate>20231127</enddate><creator>AINSWORTH William, B</creator><creator>KYE Steve, H</creator><creator>HAYSLIP John</creator><scope>EVB</scope></search><sort><creationdate>20231127</creationdate><title>VENETOCLAX DOSING REGIMENS FOR USE IN TREATING MYELODYSPLASTIC SYNDROMES IN COMBINATION WITH AZACITIDINE</title><author>AINSWORTH William, B ; KYE Steve, H ; HAYSLIP John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2023013364A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>AINSWORTH William, B</creatorcontrib><creatorcontrib>KYE Steve, H</creatorcontrib><creatorcontrib>HAYSLIP John</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>AINSWORTH William, B</au><au>KYE Steve, H</au><au>HAYSLIP John</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VENETOCLAX DOSING REGIMENS FOR USE IN TREATING MYELODYSPLASTIC SYNDROMES IN COMBINATION WITH AZACITIDINE</title><date>2023-11-27</date><risdate>2023</risdate><abstract>The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine for treating myelodysplastic syndromes (MDS).
La invención que se describe en el presente documento se refiere a regímenes de dosificación terapéutica que comprenden la administración de venetoclax en combinación con azacitidina para el tratamiento de los síndromes mielodisplásicos (MDS).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_MX2023013364A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | VENETOCLAX DOSING REGIMENS FOR USE IN TREATING MYELODYSPLASTIC SYNDROMES IN COMBINATION WITH AZACITIDINE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T10%3A26%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=AINSWORTH%20William,%20B&rft.date=2023-11-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2023013364A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |